TECOGEN INC. (TGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TECOGEN INC. on December 12, 2023, regarding an event that occurred on December 9, 2023. The filing addresses a significant change in the company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance matters and does not contain financial performance data.
Material Changes
- Departure of Director: The Board announced the death of Mr. Fred Holubow, a director and member of the Audit Committee since June 2020.
- Effective Date: Mr. Holubow passed away on December 9, 2023.
Management Commentary and Background
The Board expressed that it is "deeply saddened" by the loss. Mr. Holubow was a General Partner of Starbow Partners, an investor in early-stage healthcare ventures. His prior experience included serving as Managing Director of William Harris Investors, Inc. (2001–2011) and Vice President of Pegasus Associates (1982–2001), a firm he co-founded.
Key Facts for Investor Verification
- Confirm the current composition of the Board of Directors and the Audit Committee following Mr. Holubow's passing.
- Verify if the company has initiated a search for a replacement director to fill the vacancy.
- Check for any subsequent filings regarding the appointment of a new Audit Committee member.